greeksoup/ stock research

Dentsply Sirona (XRAY) FY2024 results: revenue $3.8 billion, down 4.3% on the year

Dentsply Sirona Inc. (XRAY) reported revenue of $3.8 billion for fiscal 2024, the year ended 31 December 2024, down 4.3% on the year before. Net income was -$910 million, and diluted earnings per share $-4.48. The figures are the company's own, from the 10-K it filed with the SEC on 27 February 2025.

Revenue
$3.8 billion
-4.3% on the year
FY2017FY2024
Operating margin
-23.2%
-2.1% a year earlier
FY2017FY2024
Net income
-$910 million
FY2017FY2024
Diluted EPS
-$4.48
FY2017FY2024

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2024 · Q2 FY2024 · Q3 FY2024 · Q4 FY2024

Income statement (profit and loss)

$ millionFY2024FY2023FY2022On the yearLast 8 years
Revenue3,7933,9653,922-4.3%
Cost of revenue1,8351,8791,795-2.3%
Gross profit1,9582,0862,127-6.1%
Gross margin51.6%52.6%54.2%
Research and development165184174-10.3%
Selling, general and administrative1,6051,6131,589-0.5%
Operating income-879-85.0-937
Operating margin-23.2%-2.1%-23.9%
Interest expense69.081.065.0-14.8%
Pre-tax income-936-175-1,055
Income tax-26.0-43.0-105
Net income-910-132-950
Net margin-24.0%-3.3%-24.2%
Diluted EPS-$4.48-$0.62-$4.41
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2024FY2023FY2022On the yearLast 8 years
Operating cash flow461377517+22.3%
Capital expenditure180149149+20.8%
Free cash flow281228368+23.2%
Free cash flow margin7.4%5.8%9.4%
Cash from investing-197-89.0-138
Cash from financing-302-307-329
Depreciation and amortisation349343328+1.7%
Share-based compensation39.046.059.0-15.2%
Buybacks250300150-16.7%
Dividends paid126116104+8.6%
Dividend per share$0.64$0.56$0.50+14.3%
Diluted shares, weighted203m212m216m-4.2%
Shares outstanding at period end199m207m215m-4.1%

Balance sheet

$ millionFY2024FY2023FY2022On the yearLast 8 years
Shareholders' equity1,9423,2933,811-41.0%
Non-controlling interest1.01.01.00.0%
Debt2,1352,1181,944+0.8%
Operating lease liabilities91.0125149-27.2%
Finance lease liabilities0.01.01.0
Other liabilities1,5841,8321,737-13.5%
Total liabilities and equity5,7537,3707,643-21.9%
Fixed assetsn/a800761
Goodwill1,5972,4382,688-34.5%
Intangible assets1,2071,7051,903-29.2%
Cash and equivalents272334365-18.6%
Inventory564624627-9.6%
Other assets2,1131,4691,299+43.8%
Total assets5,7537,3707,643-21.9%

10-K for the year ended 31 December 2024, filed 27 February 2025: the filing.